MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, EBS made $231,100K in revenue. $51,200K in net income. Net profit margin of 22.15%.

Income Overview

Revenue
$231,100K
Net Income
$51,200K
Net Profit Margin
22.15%
EPS
$0.91
Unit: Thousand (K) dollars
Revenue Breakdown
    • United States Government
    • Non United States Government
    • Non United States Government
    • Others
Revenue Breakdown
    • Product And Service
    • Contracts And Grants
Revenue Breakdown
    • United States Government
    • Non United States Government
Revenue Breakdown
    • MCMProducts Segment
    • Commercial Products Segment
    • Material Reconciling Items

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Total revenues
231,100 140,900 222,200 249,933
Cost of product and services sales, net
85,900 66,900 88,500 21,100
Research and development
13,500 12,500 15,100 18,967
Selling, general and administrative
38,900 43,700 52,400 179,800
Amortization of intangible assets
16,300 16,200 16,300 47,000
Impairment of long-lived assets
0 0 -40,800
Total operating expenses
154,600 139,300 172,300 307,667
Income (loss) from operations
76,500 1,600 49,900 -57,733
Interest expense
15,200 14,700 14,700 20,900
Gain (loss) on sale of business and assets held for sale
0 ---13,333
Loss on assets held for sale
-0 -12,200 -
Other, net
-3,700 -3,700 69,700 -3,133
Total other income (expense), net
-18,900 -18,400 42,800 -37,367
Income (loss) before income taxes
57,600 -16,800 92,700 -95,100
Income tax provision
6,400 -4,800 24,700 6,700
Net income (loss)
51,200 -12,000 68,000 -101,800
Basic (in dollars per share)
0.96 -0.22 1.25 -1.92
Basic (in shares)
53,200,000 54,200,000 54,400,000 -33,333.333
Diluted (in dollars per share)
0.91 -0.22 1.19 -1.887
Diluted (in shares)
56,500,000 54,200,000 57,300,000 -866,666.667
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Non United StatesGovernment$4,600K United StatesGovernment$9,100K Non United StatesGovernment$19,300K United StatesGovernment$123,200K Non United StatesGovernment$74,200K United StatesGovernment$700K All Other Revenue$13,700K MedicalCountermeasures MCMProduct$142,500K Commercial Product$74,900K Total revenues$231,100K Income (loss) fromoperations$76,500K Total operatingexpenses$154,600K Income (loss) beforeincome taxes$57,600K Total other income(expense), net-$18,900K Amortization of intangibleassets$16,300K Selling, general andadministrative$38,900K Research and development$13,500K Cost of product andservices sales, net$85,900K Net income (loss)$51,200K Income tax provision$6,400K Other, net-$3,700K Interest expense$15,200K

Emergent BioSolutions Inc. (EBS)

Emergent BioSolutions Inc. (EBS)